TREA

Nicole Cathleen GOODWIN

Follow

Person

  • King of Prussia, PA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Ether linked triazoles as NRF2 activators
    • Patent number 12,091,409
    • Issue date Sep 17, 2024
    • Astex Therapeutics Limited
    • Anthony William James Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Bisaryl heterocycles as NRF2 activators
    • Patent number 11,117,905
    • Issue date Sep 14, 2021
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • James Francis Callahan
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Bisaryl amides as NRF2 activators
    • Patent number 11,078,216
    • Issue date Aug 3, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Ether linked triazoles as NRF2 activators
    • Patent number 11,059,816
    • Issue date Jul 13, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • Anthony William James Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Nrf2 regulators
    • Patent number 10,604,509
    • Issue date Mar 31, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. Kerns
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    Nrf2 REGULATORS
    • Publication number 20230047296
    • Publication date Feb 16, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. KERNS
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ETHER LINKED TRIAZOLES AS NRF2 ACTIVATORS
    • Publication number 20220089590
    • Publication date Mar 24, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Anthony William James Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BISARYL LACTAMS AS NRF2 ACTIVATORS
    • Publication number 20220002272
    • Publication date Jan 6, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey Charles BOEHM
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Nrf2 REGULATORS
    • Publication number 20200079759
    • Publication date Mar 12, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. KERNS
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ETHER LINKED TRIAZOLES AS NRF2 ACTIVATORS
    • Publication number 20200071317
    • Publication date Mar 5, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Anthony William James COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BISARYL HETEROCYCLES AS NRF2 ACTIVATORS
    • Publication number 20200062781
    • Publication date Feb 27, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Francis CALLAHAN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BISARYL AMIDES AS NRF2 ACTIVATORS
    • Publication number 20190330238
    • Publication date Oct 31, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Francis CALLAHAN
    • C07 - ORGANIC CHEMISTRY